Pulmonary Arterial Hypertension Market By Product Type (Branded and Generics), By Route of Administration (Oral, Intravenous/ Subcutaneous, and Inhalational), By Drug Class (Endothelin Receptor Antagonists (ERAs), SGC Stimulators, Prostacyclin and Prostacyclin Analogs, and PDE-5 Inhibitors), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: March 2025
- Report ID: 142618
- Number of Pages: 227
- Format:
-
-
-
- Viatris Inc
- United Therapeutics Corporation
- Keros Therapeutics
- Johnson & Johnson
- Janssen Pharmaceutical Companies
- GlaxoSmithKline
- Gilead Sciences, Inc
- Bayer AG Company Profile
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible